Skip to main content

Animations

MJFF Publications

3121 - 3130 of 8808 Results
Title
Year
  • Year
  • 2013
  • 2008
  • 2013
  • 2015
  • 2016
  • 2016
  • 2014
  • 2016
  • 2007
  • 2010
  • Summary Details
    OPEN
    Title: α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.03.038
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-008-0450-7
    Citation Count: 218
  • Summary Details
    OPEN
    Title: Dopamine and its metabolites in cathepsin D heterozygous mice before and after MPTP administration
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2013.01.035
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Onset of Mild Cognitive Impairment in Parkinson Disease
    Journal Name: Alzheimer Disease & Associated Disorders
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wad.0000000000000088
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia
    Journal Name: Alzheimer Disease & Associated Disorders
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wad.0000000000000161
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Free‐water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO‐B inhibitor
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.23213
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Regulation of caspase-3 processing by cIAP2 controls the switch between pro-inflammatory activation and cell death in microglia
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/cddis.2014.514
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson’s Disease
    Journal Name: Aging and disease
    Publisher: Aging and Disease
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.14336/ad.2016.0505
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Myelin Basic Protein-primed T Cells Induce Neurotrophins in Glial Cells via α5β3 Integrin
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.m702899200
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson’s disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.09.007
    Citation Count: 40
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.